An early bactericidal activity, safety and tolerability of GSK3036656 in subjects with drug-sensitive pulmonary tuberculosis

Trial Identifier:	201214
Sponsor:	GlaxoSmithKline
Start Date:	March 2019
Primary Completion Date:	December 2021
Study Completion Date:	December 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
South Africa	Cape Town, South Africa, 7530

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.